$179.950
+0.018 (+0.01%)收盘时
MASI 资讯
MASI 事件
Tech Stocks Lead Major Averages Higher, S&P 500 Up 0.89%
The major averages finished broadly higher as technology shares led gains ahead of a stretch of earnings from some of the market's largest companies.The focus this week is on corporate earnings, with Alphabet, Tesla, IBM and Intel all set to report in the coming days. Investors are looking for signs that spending on artificial intelligence continues to translate into revenue growth and profitability after recent volatility in chip stocks raised questions about lofty valuations across the sector.Get caught up quickly on the top news and calls moving stocks with these five Top Five lists.1. STOCK NEWS:General Motorsreportedand raised its FY26 adjusted earnings guidance3Mprovided areport for Q2Hasbroalso provided areport for Q2Novo Nordiskis suing Eli LillyoverIntersnack GroupUtz Brandsfor $14.25 per share in cash2. WALL STREET CALLS:Adobeto Underweight at Morgan StanleyFive Belowto Outperform at BernsteinSalesforceto Equal Weight at Morgan StanleyRalph Laurento Outperform at Raymond JamesShopifyto Neutral at Rothschild & Co Redburn3. AROUND THE WEB:A federal judge has upheld a $634M jury verdict against Applefor infringing Masimopatents related to Apple Watch heart rate monitoring technology, Bloomberg reportsOraclemay have to face over $7B in collateral requirements after Wisconsin's power regulator tightened credit requirements, FT reportsInteltold Business Insider that it is planning layoffs within its data center groupTSMCplans to raise chipmaking prices by up to 10% from 2027 to offset rising costs for materials, manufacturing equipment and overseas plant construction, Nikkei Asia reportsTencentis in talks to acquire SuperPlay in a deal valuing the Israeli game developer at $1B-$1.5B, CTech says4. MOVERS:Forward Airhigher afterwith one of its largest customersMerlinincreases after Northlandcoverage of the stock with an Outperform ratingCoinbasegains after U.S. Treasury Secretary Scott Bessentthat the Digital Asset Market Clarity Act is nearing approval in the U.S. SenateTwenty One Capitallower after announcing CEO Jack MallersEquifaxfalls afterand raising its guidance for FY265. EARNINGS/GUIDANCE:D.R. Horton, with EPS and revenue beating consensusPeoples Bancorp, with CEO Tyler Wilcox "pleased with the results"Danaher, provided guidance for Q3 and FY26, and raised its outlook for FY26Novartis, with CEO Vas Narasimhan calling it "a solid second quarter"Calixand provided guidance for Q3 and FY26INDEXES:The Dow rose 385.38, or 0.74%, to 52,224.64, the Nasdaq gained 329.13, or 1.29%, to 25,837.21, and the S&P 500 advanced 65.92, or 0.89%, to 7,509.20.
Masimo Shareholders Approve Merger Agreement with Danaher
Masimo (MASI) announced that its stockholders voted in favor of the proposal to adopt the previously announced Agreement and Plan of Merger, dated February 16, 2026, by and among Masimo, Danaher Corporation (DHR) and Mobius Merger Sub at Masimo's special meeting of stockholders held virtually on May 1, 2026. Under the terms of the Merger Agreement, at the effective time of the merger of Merger Sub with and into Masimo, each share of common stock issued and outstanding immediately prior to the effective time of the Merger will be canceled and automatically converted into the right to receive $180.00 in cash, without interest. Katie Szyman, Chief Executive Officer of Masimo, stated: "We thank our shareholders for their strong support of this important milestone for Masimo. The Merger delivers compelling value and positions Masimo for continued global growth as an independent operating company within Danaher's Diagnostics segment. We look forward to completing this process and, together with Danaher, continuing our mission of developing innovative technologies that empower clinicians to transform patient care."
Masimo Awarded $100M Contract Modification
Masimo has been awarded a maximum $100M modification exercising the five-year option period of a five-year base contract with one five-year option period for patient monitoring and capital equipment. This is a fixed-price with economic-price-adjustment, indefinite-delivery/indefinite-quantity contract. The ordering period end date is April 19, 2031. Using customers are Army, Navy, Air Force, Marines Corps, and federal civilian agencies. Type of appropriation is fiscal 2026 through 2031 defense working capital funds. The contracting activity is Defense Logistics Agency Troop Support.
本页仅供研究参考,不构成投资建议。模型可能出错。过往表现不代表未来结果。








